Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density

NCT04597931 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT04597931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04597931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density
Lead sponsor
Sheba Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
November 1, 2020
Completion date
November 15, 2023
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis fracture, spinal cord injuries